VAQTA® (Hepatitis A Vaccine, Inactivated) is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older. The primary dose should be given at least 2 weeks prior to expected exposure to HAV.

2024年1月11日 · The United States Food and Drug Administration (FDA) has licensed two single-antigen hepatitis A vaccines (Havrix and Vaqta) and one combination vaccine for protection against both hepatitis A and hepatitis B (Twinrix) for use in the US.

2020年10月26日 · Tradename: VAQTA Manufacturer: Merck Sharp & Dohme Corp. Indications: For the prevention of disease cause by hepatitis A virus (HAV) in persons 12 months of age and older. Product Information

• VAQTA is a vaccine that helps prevent Hepatitis A. Hepatitis A is an infection of the liver. • It is a vaccine for people 12 months of age and older. What do you need to know about VAQTA? •...

VAQTA® [Hepatitis A Vaccine, Inactivated] is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older. The primary dose should be given at...

2024年11月20日 · VAQTA is an inactivated whole virus vaccine derived from hepatitis A virus grown in cell culture in human MRC-5 diploid fibroblasts. It contains inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain.

Find patient medical information for Vaqta intramuscular on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

2024年12月3日 · Hepatitis is a serious disease caused by a virus. Hepatitis causes inflammation of the liver, vomiting, and jaundice (yellowing of the skin or eyes). Hepatitis can lead to liver cancer, cirrhosis, or death. The Vaqta is used to help prevent this disease in adults.

2024年10月11日 · Detailed drug Information for Vaqta. Includes common brand names, drug descriptions, warnings, side effects and dosing information.

2024年12月17日 · [HEPATITIS A VACCINE, INACTIVATED] VAQTA ® ADULT FORMULATION. This package contains 10 single-dose syringes. Each 1-mL syringe contains approximately 50U of hepatitis A virus antigen on an amorphous aluminum hydroxyphosphate sulfate adjuvant. Hepatitis A virus is grown in cell culture in human MRC-5 diploid fibroblasts. Rx only

Find patient medical information for Vaqta (PF) intramuscular on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Indicated as active immunization for any person seeking protection and for persons at risk for HAV infection. At risk populations. 2-dose vaccination series. Preexposure protection against HAV for...

VAQTA® (Hepatitis A Vaccine, Inactivated) is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older. The primary dose should be given at least 2 weeks prior to expected exposure to HAV.

VAQTA® (Hepatitis A Vaccine, Inactivated) is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older. The primary dose should be given at least 2 weeks prior to expected exposure to HAV.

Hepatitis A (HepA) vaccines are prepared from formalin-inactivated, cell culture–derived hepatitis A virus. Both vaccines are available in pediatric and adult formulations. A combined hepatitis A vaccine/hepatitis B vaccine is also available.

2024年11月7日 · Detailed dosage guidelines and administration information for Vaqta (hepatitis A vaccine, inactivated). Includes dose adjustments, warnings and precautions.

2024年5月2日 · Learn about the side effects of Vaqta (hepatitis a adult vaccine), from common to rare, for consumers and healthcare professionals.

Find drug information for Vaqta on CVS.com, including related drug classes, side effects, dosage, and answers to frequently asked questions.

VAQTA® (Hepatitis A Vaccine, Inactivated) is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older. The primary dose should be given at least 2 weeks prior to expected exposure to HAV. Dosage and Administration for VAQTA.

VAQTA® (Hepatitis A Vaccine, Inactivated) is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older. The primary dose should be given at least 2 weeks prior to expected exposure to HAV.